The DRUG Act Would Not Lower Drug Prices But Would Increase Costs for Taxpayers, Employers and Patients
Transparency Measures That Promote Patient Care and Preserve Competition
Rebate Mandates Hurt Choice and Small Employers
Implications of the Drug Act
HR 9096 Would Increase Federal Health Care Program Costs
Enacting Delinking Would Ban Spread Pricing Talking Points
The Economic Impact of ‘Delinking’ (Explainer, 2023)
The Economic impact of Delinking laws
